FTC Releases Second Report Slamming Pharmacy Benefit Managers
The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S., in the latest and likely last salvo between antitrust regulators in the Biden administration and the controversial middlemen in the drug supply chain. The report accuses CVS’ Caremark, […]
FTC Releases Second Report Slamming Pharmacy Benefit Managers Read More »